Lauriello, John
Weiden, Peter J.
Gleeson, Carole D.
Shah, Ankit
Boulanger, Luke
Jariwala-Parikh, Krutika
Hedgeman, Elizabeth
O’Sullivan, Amy K.
Funding for this research was provided by:
Alkermes, Inc.
Article History
Accepted: 17 July 2021
First Online: 21 September 2021
Declarations
:
: This study was funded by Alkermes, Inc. The open access fee was paid by Alkermes, Inc.
: AKO, CDG, AS, and PJW were employed by Alkermes, Inc., at the time this research was conducted. LB, KJP, and EH were employed by IBM Watson Health at the time this research was conducted and received funding from Alkermes, Inc., to conduct this study. JL is a paid consultant of Alkermes, Inc., although he was not paid for his time on this article.
: All database records are statistically de-identified and certified to be fully compliant with US patient confidentiality requirements set forth in the Health Insurance Portability and Accountability Act of 1996. Because this study used only de-identified patient records and did not involve the collection, use, or transmittal of individually identifiable data, institutional review board approval to conduct this study was not necessary.
: Not applicable.
: Not applicable.
: The data that support the findings of this study are available from IBM Watson Health. Restrictions apply to the availability of these data, which were used under license for this study.
: Not applicable.
: JL, CG, LJB, AS, AOS, EH, KJP, PW contributed to the design of the study and interpretation of the data. AOS, EH, KJP, PW, contributed to the data collection and data analysis. All authors critically revised the draft manuscript and approved the final content and are accountable for the work presented.